Blocking IL-6 can result in less apparent symptoms of infection (e.g., lower fever or less pronounced leukocytosis), leading to delayed diagnosis and potentially higher severity of the infection (Sepriano et al., 2023). Here, IL6 is linked to Increased total leukocyte count.